perifosine has been researched along with Genital Neoplasms, Female in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aoki, D; Aoki, Y; Hasegawa, K; Kagabu, M; Kamiura, S; Kimura, T; Mabuchi, S; Mizuno, M; Ochiai, K; Oda, K; Okamoto, A; Saito, T; Takehara, K; Yamaguchi, S; Yunokawa, M | 1 |
1 trial(s) available for perifosine and Genital Neoplasms, Female
Article | Year |
---|---|
Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutations.
Topics: Adult; Aged; Class I Phosphatidylinositol 3-Kinases; Cohort Studies; Female; Follow-Up Studies; Genital Neoplasms, Female; Humans; Middle Aged; Mutation; Neoplasm Recurrence, Local; Phosphorylcholine; Prognosis | 2017 |